InvestorsHub Logo

rosemountbomber

07/24/15 5:24 AM

#54303 RE: Sam81 #54302

Thanks Sam. Wonder if and what Ricardoga will be piping in about this.

rafunrafun

07/24/15 6:14 AM

#54304 RE: Sam81 #54302

Here's a big thanks to AMRN and KOWA sales reps. Keep up the good and hard work!!!

north40000

07/24/15 1:48 PM

#54348 RE: Sam81 #54302

The scripts may be a big reason accounting for Watson's[AGN's] interest in maintaining a semblance of 1st filer status. Ziploc pointed out yesterday that AGN's Restasis activity in treating DES
leaves something to be desired. Several of us, including me, as well as the literature posted by Zumantu, have pointed out that Vascepa is effective in treating DES. For me, that is definitely off-label use as prescribed by my physician, as a result of info provided by me to him. The 1st Amendment case becomes even more important in that light to enable AMRN to reach physicians with truthful, not misleading, information about that indication.

All of the above could accelerate an AGN interest in a TO for AMRN.